Holtec Nuclear delays IPO as Nscale eyes multibillion dollar debut
Holtec Nuclear abruptly postponed its $825 million IPO while Nscale filed for a potential $2 billion offering and Electra Therapeutics suffered a rare biotech IPO drop.
Monoclonal antibody 1 article
Single-clone antibody specificity provides the clearest boundary for monoclonal antibody, a single-specificity antibody therapeutic format used in a specific molecular or clinical context. The entity links antigen-binding variable regions to immunoglobulin therapeutic proteins, and its relevance becomes clearer through antibody affinity maturation and Fc-mediated effector function rather than through broader terminology. A monoclonal antibody is defined by a single antibody clone and specificity; bispecific antibodies deliberately combine two binding specificities in one engineered molecule.